PerkinElmer spends $5.3B on its fourth acquisition this year
July 26, 2021 at 11:39 AM EDT
Life sciences giant PerkinElmer Inc. (NYSE: PKI) is making yet another acquisition, this time the biggest in its history, buying San Diego, Calif.-based BioLegend for $5.25 billion in cash and stock.
